The Johns Hopkins Kimmel Cancer Center leads the field in scientific inquiry and sets the pace in the race to cure cancer. Our doctors and researchers are at the vanguard of discovery, implementation and treatment. Our podcast provides a glimpse at the work they do to combat cancer and the leading care that our state-of-the-art facilities provide.
Kimmel is DC with Dr Ashwani Rajput - The Brady Urological Institute
Dr Ashwani Rajput speaks with Dr Gerald Andriole, Director of the Johns Hopkins Brady Urological Institute in the National Capital Region, about the treatment of prostate cancer and The Brady's commitment to excellent patient care, breakthrough research, and training of the next generation of physicians.
Kimmel in DC with Dr Ashwani Rajput - Community Outreach & Engagement
Dr Ashwani Rajput talks with Dina Lansey, Associate Deputy Director of Community Outreach and Engagement, about the Kimmel Cancer Center's efforts to partner with our communities to address cancer disparities and improve healthcare outcomes.
Cancer Matters with Dr Bill Nelson - Reducing the Risk of Ovarian Cancer
Dr Bill Nelson speaks with Dr Rebecca Stone about a new approach to reducing the risk of ovarian cancer.
Cancer Matters with Dr Bill Nelson - DNA Test Can Guide Stage II Colon Cancer Treatment
Dr Bill Nelson talks with Dr Anne Marie Lennon from the Johns Hopkins Kimmel Cancer Center and Dr Jonathan Simons from the Marcus Foundation about a significant study that shows the majority of patients with stage II colon cancer no longer need chemotherapy following surgery.
Kimmel In DC with Dr Ashwani Rajput - Major Advance in the Treatment of Lung Cancer
Dr Ashwani Rajput talks with Dr Ben Levy from Sibley Memorial Hospital about the results of the Checkmate-816 clinical trial, which is leading to major changes in the way patients with non-small cell lung cancer are being treated. Click here to learn more about the Checkmate-816 trial.
Cancer Matters with Dr Bill Nelson - The Checkmate-816 Trial
Dr Bill Nelson speaks with Dr Patrick Forde about the results of a clinical trial that show pairing immunotherapy treatments with chemotherapy greatly increases survival in patients with lung cancer.
Read more about the Checkmate-816 Trial here.
This Integrative Medicine push has really tarnished the reputation of Johns Hopkins Medicine.